Existing drugs may hold the key to treating rare diseases, says Cambridge charity
Findacure, a rare diseases charity based in Cambridge, says repurposing existing drugs to treat rare diseases will improve patient outcomes and save the NHS money.
Stocks in Focus: DS Smith
This week Oliver Phillips of NW Brown revisits DS Smith following its recent capital markets day, where they invited investors and analysts to visit one of its facilities in Germany.
Cresset publishes January 2017 newsletter
The latest computational chemistry news from Cresset.
InnaSpa's brand new bike will be making its way around Cambridge
Snap a selfie with InnaSpa's bike...
Finding new cancer drugs in the neighbourhood
Computational biologists have looked at the complex networks of interacting proteins that drive cancer formation, and found that targeting the neighbours of cancer-causing proteins may be just as effective as focusing on the cancer proteins themselves.
David Cameron announced as President of Alzheimer’s Research UK
Former Prime Minister David Cameron has been announced as the new President of Alzheimer’s Research UK, the UK’s leading dementia research charity.
Top spot for KISS for third year running
KISS has been voted No 1 in Business Weekly’s New Year Honours ‘Image Makers’ award for the third year running.
Cambridge MP invites residents to participate in RSPB Big Garden Birdwatch
The RSPB Big Garden Birdwatch (#BigGardenBirdwatch) is taking place this weekend (28th to 30th January). Across the country, everyone is invited to become a citizen scientist and take an hour to record the birds they see in their garden.
Cresset corporate rebrand reflects new structure for growing company
Cresset, innovative provider of software and contract research services for small molecule discovery and design, is pleased to announce a corporate rebrand, reflecting a new structure for this growing business.
Opinion: Parliament needs to load the Article 50 gun before Prime Minister triggers Brexit
Cambridge’s Professor of European Law, Kenneth Armstrong, reacts to the Supreme Court’s landmark ruling yesterday (Tuesday).
Point-of-care ultrasound helps emergency care at King's College Hospital
The Emergency Department at King's College Hospital NHS Foundation Trust is a busy trauma centre dealing with over 400 cases every day. Point-of-care ultrasound has been used in the department for over 10 years, and now forms an integral part of many patient assessment pathways.
Biofortuna expands its immunoassay development and manufacturing services
Biofortuna is expanding its IVD service portfolio to provide a greater focus on immunoassay design, development and manufacture.
PowerPoint presentation builder gives Cushman & Wakefield headstart against the competition
Cushman & Wakefield, a leading global real estate services firm, reveal how a recent software implementation has transformed the way their teams work, and played a crucial role in coordinating and standardising internal systems and centralising media management.
CUH named as specialist radiotherapy centre
Cambridge University Hospitals (CUH) has been named as a specialist provider for an advanced form of radiotherapy to help treat patients with life-threatening brain tumours.
Prism facilitates sale of Docucentric Holdings to Arena Group
Prism is delighted to announce the sale of the North West’s leading regional managed print services (MPS) group, Docucentric Holdings Ltd (DHL) to Arena Group Holdings Ltd (Arena).
Improve your company’s green credentials and profitability with a free energy audit
The Business Energy Advice for Cambridgeshire and Peterborough (BEE-CP) scheme delivers free independent energy advice and grant funding to businesses in the Greater Cambridge Greater Peterborough Enterprise Partnership (LEP) area over the next two years.
Supreme Court judgment: business now looking to EU
Karen Briggs, Head of Brexit at KPMG, comments on today’s Supreme Court judgment: “As expected, the Government has lost its appeal on whether an Act of Parliament is needed before Article 50 can be triggered.
Breast cancer fundraisers help improve treatment for patients at Addenbrooke’s
Addenbrooke’s Charitable Trust yesterday (Monday) held a tea party at the hospital’s Cambridge Breast Unit to celebrate an amazing total of over £60,000 raised for the charity’s Addenbrooke’s Breast Cancer Appeal 2016.
Cambridge Network's CEO comments on the government's new industrial strategy
Following an appearance with other Cambridge commentators on BBC Radio 4's Today programme on Monday, Cambridge Network's CEO Claire Ruskin gives her views on Theresa May's new industrial strategy.
Does your brand need a tune-up?
If your brand is struggling to keep growing in a stagnant or declining market; being impacted by shiny new competitors making your market seem more exciting and by default you old-fashioned and dusty; or you’re simply realising that the rules changed somehow when you weren’t looking and now you’re not sure of your direction...you need a brand tune-up.
Latest data from Cambridge Ahead shows unabated growth of Cambridge companies
New data shows that the remarkable growth of Cambridge companies that was revealed for 2014-15 continued in 2015-16.
Cambridge Index declines 1.7%
The Cambridge Index fell 1.7% or 404.55 points to finish at 22,775.2 as seven of the top ten Index heavyweights posted losses to their share prices.
Genestack launches new brand and corporate logo
Genestack, a bioinformatics company based in Cambridge, launches its new brand and corporate logo. The rebranding reflects the evolution of the company during its five-year history and illustrates the company's vision and ambitions for the future.
The Supreme Court decides: Parliament is Sovereign
In the most significant judgment concerning the UK’s constitution in generations, the Supreme Court (a majority of 8 to 3) has rejected the UK Government’s case that ministers could start the process of withdrawal from the European Union without the authority of Parliament.
UCSF first to adopt Magseed as standard of care for localization of impalpable breast lesions
Endomag, the cancer healthcare company, announced that the University of California, San Francisco (UCSF) has become the first US site to adopt Magseed™ as its standard of care for localization of impalpable breast lesions. Magseed™ is a simpler, more effective alternative to traditional wire localization methods.